logo
CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue

CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue

Associated Press2 hours ago
CREMONA, AB / ACCESS Newswire / August 19, 2025 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an emerging leader in global cannabis cultivation and exports, announces a series of strategic developments. The goal is to strengthen its international footprint and production capacity.
The company continues to make significant steps in its mission to supply premium cannabis products to high-demand international markets, including Germany, Portugal, and Israel. Here's an overview of their recent shipments along with the Q3 revenue estimate.
Major Cannabis Shipments to Europe
Building on its successful export operations, CannaPharmaRX has completed its second shipment to Germany in July by delivering 139.6 kilograms. Demand remains strong in Germany for our product, and we continue to take new orders for our strains.
In August, the company plans to execute two additional shipments to Germany and Portugal totaling 300 kilograms:
● 180.2 kg of high-THC products marking continued interest in our premium products.
● 119.8 kg of low-THC products for the more economical strains that we are producing.
Expanding Presence in Israel
In addition to its European exports, CannaPharmaRX is also preparing a shipment of
approximately 142 kg of medium-quality cannabis buds to Israel. This is another step in the company's strategy to diversify its customer base and strengthen trade relationships in international markets. We are deliberately growing strains that cater to different consumers and different pricing needs so that we are scaling across all sectors.
Scaling Up Production with a New Growing Room
To meet increasing demand, CannaPharmaRX plans to open its sixth growing room in
September, bringing it closer to its total capacity of ten potential grow rooms. The expansion will also allow the company to cultivate new, recently tested cannabis varieties that have delivered promising results during trials.
Strong Q3 Revenue Forecast
The company projects third-quarter revenues of approximately $1,050,000 CAD, with the anticipation of additional shipments before the end of September. This forecast may vary slightly depending on fluctuations in the Euro-to-Canadian Dollar exchange rate.
CTO Update
CannaPharmaRX continues to address regulatory matters in Canada with the BCSC. The company will submit a detailed response to the latest communication received in May by the end of August, with legal guidance from Fasken Law Firm.
Contact:
Company: CannapharmaRx
Name: Constantine Nkafu
Website: https://cannapharmarx.com
Phone: 403-637-0420
Mail: [email protected]
SOURCE: CannaPharmaRx
press release
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Microsoft Workers Protesting Israel Ties Say They've Occupied HQ
Microsoft Workers Protesting Israel Ties Say They've Occupied HQ

Yahoo

time2 hours ago

  • Yahoo

Microsoft Workers Protesting Israel Ties Say They've Occupied HQ

(Bloomberg) -- Microsoft Corp. employees have started setting up a protest encampment at the company's Redmond, Washington, headquarters, ratcheting up a campaign calling for company to stop doing business with Israel over its war in Gaza. Why New York City Has a Fleet of New EVs From a Dead Carmaker Chicago Schools Seeks $1 Billion of Short-Term Debt as Cash Gone A Photographer's Pipe Dream: Capturing New York's Vast Water System A London Apartment Tower With Echoes of Victorian Rail and Ancient Rome Trump Takes Second Swing at Cutting Housing Assistance for Immigrants Protesters started gathering Tuesday afternoon at a plaza at the center of a recently redeveloped portion of the company's main campus, which extends over about 500 acres in the suburban town east of Seattle. They circulated a 3,300-word declaration outlining their aims and invited Microsoft executives to come to the negotiating table. A Microsoft employee group, No Azure for Apartheid, has for more than a year been pushing Microsoft to end its relationship with Israel, saying use of the company's products is contributing to civilian deaths in Gaza. Azure, the company's cloud-computing division, sells on-demand software and data storage to businesses and governments, including Israeli government and military agencies. A handful of No Azure for Apartheid organizers have been fired, for holding what Microsoft said was an unauthorized event on campus and disrupting speeches by executives. 'Microsoft is the most complicit digital arms manufacturer in Israel's genocide of Gaza,' Nisreen Jaradat, a Microsoft employee, said in a statement on Tuesday. Microsoft in a blog post published in May said it had 'found no evidence to date that Microsoft's Azure and AI technologies have been used to target or harm people in the conflict in Gaza.' But the company said this month that it had enlisted the law firm Covington & Burling to conduct a further review after a report that Israel's military surveillance agency intercepted millions of mobile phone calls made by Palestinians in Gaza and the West Bank and stored them on Azure servers. That trove helped inform the selection of bombing targets in Gaza, according to reporting by the Guardian newspaper, Israeli-Palestinian publication +972 Magazine, and Local Call, a Hebrew-language news site. The activists took their inspiration from encampment-style protests staged on at least 100 US college campuses since the war in Gaza began. Students at schools like Columbia University pitched tents and called for their colleges to divest financial holdings tied to Israel and US weapons makers, in many cases sparking disciplinary action from administrators. Foreigners Are Buying US Homes Again While Americans Get Sidelined What Declining Cardboard Box Sales Tell Us About the US Economy Women's Earnings Never Really Recover After They Have Children Americans Are Getting Priced Out of Homeownership at Record Rates Yosemite Employee Fired After Flying Trans Pride Flag ©2025 Bloomberg L.P. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Liverpool Transfer News: Double-deal derails £50m playmaker move
Liverpool Transfer News: Double-deal derails £50m playmaker move

Yahoo

time2 hours ago

  • Yahoo

Liverpool Transfer News: Double-deal derails £50m playmaker move

Liverpool had been hoping to agree a transfer with RB Leipzig for one of the club's brightest talents on the basis that one of the German club's big stars is likely to join Chelsea this summer. However, the latest update suggests that Leipzig have decided to turn their attention elsewhere. 🔴 Shop the LFC 2025/26 adidas home range 🚨2025/26 LFC x adidas range🚨 LFC x adidas Shop the home range today! LFC x adidas Shop the goalkeeper range today LFC x adidas Shop the new adidas range today! The player in question is Harvey Elliott, who has seemingly been pushed out of Liverpool, despite having a really impressive start to his career on Merseyside. His performances in the first team have been positive but our transfer business has meant that his game time is increasingly limited. 🔴 Winning the U21 Euros looked to be the catalyst for an expensive move away, since he won the player of the tournament award, but none of his linked clubs appear to be interested anymore. Reports coming out of Leipzig now suggest that a new target has been pivoted to instead of him. Leipzig and Chelsea double-deal It always looked likely that Xavi Simons would join Chelsea, despite the illustrious depth they have in attacking areas. Enzo Marseca used six forwards throughout the Blues' 0-0 draw to Crystal Palace on the weekend and still no breakthrough came. As such, the Dutchman's move is likely to happen. That would have left Leipzig with a creative hole in their team and plenty of money to spend on a replacement, with interest having been lodged in Elliott, although no actual bid has been made. In Tuesday's dealsheet from The Athletic, it was understood that the Englishman remained a potential replacement for Simons, although his move has now been significantly derailed. The update stems from David Ornstein's understanding that Leipzig are now looking at bringing Christopher Nkunku back to the club, with talks stepping up with Chelsea for a permanent move. In his report, he said: "A deal for Nkunku to return to Leipzig is not considered close at this stage, and other forward options remain in play for the forward. The 27-year-old has been expected to leave this summer, with The Athletic reporting in November that he was not happy at the club." However, this move appears to make sense for all parties, except for the fact that the German club are swapping a 22-year-old for a player five years older, which is a bold decision given how young the current Leipzig squad is. You feel it's a bit of an opportunistic move to revive Nkunku's career. It would represent a double-deal between Leipzig and Chelsea, with one attacking player moving in order to make room for the other to take his place, with the finances for the moves relatively similar. Elliott will likely be stuck without a move this summer if the deal goes through since Liverpool hold the player in high esteem, especially since his campaign in the Euros last season, although where Arne Slot will play him this season, if at all, is going to cause headaches since he was set to leave. The player's desire to succeed at Liverpool has never been in doubt, to the extent that he was only considering a move away from Merseyside because it appeared to be the best decision for his career, rather than because he wants to leave. The fans and his teammates mean everything to him. As such, we're in a sticky situation. Of course, having a player of his talent to utilise this season is going to help bolster the side, he just wasn't in the initial plans which means Slot might have to rethink his tactical approach if a new suitor in the transfer market can't be found before September 1.

CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue
CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue

Associated Press

time2 hours ago

  • Associated Press

CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue

CREMONA, AB / ACCESS Newswire / August 19, 2025 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an emerging leader in global cannabis cultivation and exports, announces a series of strategic developments. The goal is to strengthen its international footprint and production capacity. The company continues to make significant steps in its mission to supply premium cannabis products to high-demand international markets, including Germany, Portugal, and Israel. Here's an overview of their recent shipments along with the Q3 revenue estimate. Major Cannabis Shipments to Europe Building on its successful export operations, CannaPharmaRX has completed its second shipment to Germany in July by delivering 139.6 kilograms. Demand remains strong in Germany for our product, and we continue to take new orders for our strains. In August, the company plans to execute two additional shipments to Germany and Portugal totaling 300 kilograms: ● 180.2 kg of high-THC products marking continued interest in our premium products. ● 119.8 kg of low-THC products for the more economical strains that we are producing. Expanding Presence in Israel In addition to its European exports, CannaPharmaRX is also preparing a shipment of approximately 142 kg of medium-quality cannabis buds to Israel. This is another step in the company's strategy to diversify its customer base and strengthen trade relationships in international markets. We are deliberately growing strains that cater to different consumers and different pricing needs so that we are scaling across all sectors. Scaling Up Production with a New Growing Room To meet increasing demand, CannaPharmaRX plans to open its sixth growing room in September, bringing it closer to its total capacity of ten potential grow rooms. The expansion will also allow the company to cultivate new, recently tested cannabis varieties that have delivered promising results during trials. Strong Q3 Revenue Forecast The company projects third-quarter revenues of approximately $1,050,000 CAD, with the anticipation of additional shipments before the end of September. This forecast may vary slightly depending on fluctuations in the Euro-to-Canadian Dollar exchange rate. CTO Update CannaPharmaRX continues to address regulatory matters in Canada with the BCSC. The company will submit a detailed response to the latest communication received in May by the end of August, with legal guidance from Fasken Law Firm. Contact: Company: CannapharmaRx Name: Constantine Nkafu Website: Phone: 403-637-0420 Mail: [email protected] SOURCE: CannaPharmaRx press release

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store